In particular, lapatinb works better when combined with other inhibitors of key pathways in melanoma, such as γ-secretase inhibitors [3], and BRAF inhibitors [8], highlighting a cooperation among different pathways in melanoma pathogenesis. This evidence concerns the gene BRAF and melanoma.